Böger CA - Search Results

1

RANTES gene polymorphisms predict all-cause and cardiac mortality in type 2 diabetes mellitus hemodialysis patients.

Böger CA, Fischereder M, Deinzer M, Aslanidis C, Schmitz G, Stubanus M, Banas B, Krüger B, Riegger GA, Krämer BK. Böger CA, et al. Atherosclerosis. 2005 Nov;183(1):121-9. doi: 10.1016/j.atherosclerosis.2005.03.006. Atherosclerosis. 2005. PMID: 15899487

2

C-reactive protein as predictor of death in end-stage diabetic nephropathy: role of peripheral arterial disease.

Böger CA, Götz A, Stubanus M, Banas B, Deinzer M, Krüger B, Holmer SR, Schmitz G, Riegger GA, Krämer BK. Böger CA, et al. Kidney Int. 2005 Jul;68(1):217-27. doi: 10.1111/j.1523-1755.2005.00396.x. Kidney Int. 2005. PMID: 15954911 Free article.

3

Effect of MTHFR C677T genotype on survival in type 2 diabetes patients with end-stage diabetic nephropathy.

Böger CA, Stubanus M, Haak T, Götz AK, Christ J, Hoffmann U, Riegger GA, Krämer BK. Böger CA, et al. Nephrol Dial Transplant. 2007 Jan;22(1):154-62. doi: 10.1093/ndt/gfl512. Epub 2006 Sep 27. Nephrol Dial Transplant. 2007. PMID: 17005529

4

RANTES/CCL5 polymorphisms as a risk factor for recurrent acute rejection.

Krüger B, Böger CA, Obed A, Farkas S, Hoffmann U, Banas B, Fischereder M, Krämer BK. Krüger B, et al. Among authors: boger ca. Clin Transplant. 2007 May-Jun;21(3):385-90. doi: 10.1111/j.1399-0012.2006.00654.x. Clin Transplant. 2007. PMID: 17488389

5

Effect of membrane flux and dialyzer biocompatibility on survival in end-stage diabetic nephropathy.

Götz AK, Böger CA, Popal M, Banas B, Krämer BK. Götz AK, et al. Among authors: boger ca. Nephron Clin Pract. 2008;109(3):c154-60. doi: 10.1159/000145459. Epub 2008 Jul 25. Nephron Clin Pract. 2008. PMID: 18663328

6

Is inflammation prior to renal transplantation predictive for cardiovascular and renal outcomes?

Krüger B, Walberer A, Debler J, Böger CA, Farkas S, Reinhold SW, Obed A, Schlitt HJ, Fischereder M, Banas B, Krämer BK. Krüger B, et al. Among authors: boger ca. Atherosclerosis. 2010 Jun;210(2):637-42. doi: 10.1016/j.atherosclerosis.2010.01.004. Epub 2010 Jan 11. Atherosclerosis. 2010. PMID: 20092820

7

Effect of HMG-CoA-reductase inhibitors on survival in type 2 diabetes patients with end stage diabetic nephropathy.

Götz AK, Böger CA, Hirschmann C, Schmitz G, Riegger GA, Krämer BK. Götz AK, et al. Among authors: boger ca. Eur J Med Res. 2005 Apr 20;10(4):155-60. Eur J Med Res. 2005. PMID: 15946911

8

Effect of genetic variation on therapy with angiotensin converting enzyme inhibitors or angiotensin receptor blockers in dialysis patients.

Böger CA, Götz AK, Krüger B, Hösl M, Schmitz G, Riegger GA, Krämer BK. Böger CA, et al. Eur J Med Res. 2005 Apr 20;10(4):161-8. Eur J Med Res. 2005. PMID: 15946912

9

Effect of ACE and AT-2 inhibitors on mortality and progression to microalbuminuria in a nested case-control study of diabetic nephropathy in diabetes mellitus type 2: results from the GENDIAN study.

Böger CA, Haak T, Götz AK, Christ J, Ruff E, Hoffmann U, Riegger GA, Krämer BK. Böger CA, et al. Int J Clin Pharmacol Ther. 2006 Aug;44(8):364-74. doi: 10.5414/cpp44364. Int J Clin Pharmacol Ther. 2006. PMID: 16961167 Clinical Trial.

10

Impact of NOD2/CARD15 haplotypes on the outcome after kidney transplantation.

Krüger B, Böger CA, Schröppel B, Obed A, Hoffmann U, Murphy BT, Fischereder M, Holler E, Banas B, Krämer BK. Krüger B, et al. Among authors: boger ca. Transpl Int. 2007 Jul;20(7):600-7. doi: 10.1111/j.1432-2277.2007.00486.x. Transpl Int. 2007. PMID: 17498224 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

112 results

Search Page